CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron denervation as proximal driver in CCL2-CCR2 Axis at NMJ: Mechanism of Selective Motor Neuron Vulnerability in ALS
How does the CCL2-CCR2 chemokine axis at the neuromuscular junction drive selective vulnerability of fast-fatigable motor neurons over slow-resistant motor neurons in ALS, and does blocking CCR2 signalling in myeloid cells reverse NMJ denervation in a cell-type-specific manner in ALS mouse models?
CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron denervation should produce a measurable proximal phenotype before late disease pathology. The decisive test is myeloid-specific CCR2 blockade with fast/slow motor-unit stratification and NMJ integrity measurements.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["CCL2 Chemokine Secretion Denervated Muscle and Schwann Cells"]
B["CCR2 Receptor Upregulation Pro-inflammatory Macrophages"]
C["CX3CR1/CCR2 Monocyte Recruitment NMJ Neuromuscular Junction"]
D["Fast-Fatigable Motor Neuron Synapse Stripping Begins"]
E[" neuromuscular Dependency Sustained Jnk/c-Jun Signaling"]
F["Denervation and Axonal Degeneration ALS Disease Progression"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
7 citations5 with PMID5 mediumValidation: 0%6 supporting / 1 opposing
✓For(6)
5
No opposing evidence
(1)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
4
2
1
MECH 4CLIN 2GENE 1EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
MCP1-CCR2 and neuroinflammation in the ALS motor c…
Study demonstrated CCL2-CCR2 drives NMJ denervatio…
Supporting
MECH
The CCL2-CCR2 a…
-
-
-
-
-
CCR2 blockade may reduce inflammation without dire…
Opposing
MECH
The CCL2-CCR2 a…
-
-
-
-
-
Legacy Card View — expandable citation cards
✓ Supporting Evidence
6
Study demonstrated CCL2-CCR2 drives NMJ denervation in ALS but noted that the mechanism of selective fast vs. …▼
Study demonstrated CCL2-CCR2 drives NMJ denervation in ALS but noted that the mechanism of selective fast vs. slow motor neuron vulnerability downstream of this axis was not resolved.
The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis
MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology.MEDIUM
CCR2 blockade may reduce inflammation without directly rescuing vulnerable motor-neuron physiology
The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-28 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Theorist position for analysis f7f8019f-08f6-428b-adff-85e8ea202b60: CCL2-CCR2 Axis at NMJ: Mechanism of Selective Motor Neuron Vulnerability in ALS
Source basis: The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis (Nature Communications, 2025, DOI 10.1038/s41467-025-62351-3). The stored gap context says: Study demonstrated CCL2-CCR2 drives NMJ denervation in ALS but noted that the mechanism of selective fast vs. slow motor neuron vulnerability downstream of this axis was not resolved.
Primary hypothesis: CCL2-CCR2 myeloid signaling as a selective driver of f
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Skeptic critique for analysis f7f8019f-08f6-428b-adff-85e8ea202b60: CCL2-CCR2 Axis at NMJ: Mechanism of Selective Motor Neuron Vulnerability in ALS
The source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: CCR2 blockade may reduce inflammation without directly rescuing vulnerable motor-neuron physiology.
The debate shou
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Domain expert assessment for analysis f7f8019f-08f6-428b-adff-85e8ea202b60: CCL2-CCR2 Axis at NMJ: Mechanism of Selective Motor Neuron Vulnerability in ALS
The practical path is feasible but should be staged. Stage 1 should reanalyze or collect human data at the needed resolution, preserving pathology, sex/genotype, region, and disease-stage covariates when relevant. Stage 2 should test CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron denervation in a model where the proximal readout can be measured before overt toxicity. Stage 3 should connect the readout to a
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
{ "ranked_hypotheses": [ { "title": "CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron denervation as proximal driver in CCL2-CCR2 Axis at NMJ: Mechanism of Selective Motor Neuron Vulnerability in ALS", "description": "CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron denervation should produce a measurable proximal phenotype before late disease pathology. The decisive test is myeloid-specific CCR2 blockade with fast/slow motor-unit stratification and NMJ integrity measurements.", "target_gene": "CCL2-CCR2",
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.
💬 Discussion
Loading comments...
No DepMap CRISPR Chronos data found for CCL2-CCR2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.